# Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy is a Foundation based in San Francisco, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** 1 Letterman Drive, Suite D3500, San Francisco, CA 94129, United States
- **Assets under management:** Undisclosed
- **Website:** parkerici.org

## Regulatory record

- **Reports private funds:** No

## About

We combined forces with the brightest minds in the field to radically change the way research is done – and save lives faster.

## Sectors

- Healthcare Services
- Digital Health

## Offices

- Boston, MA, United States
- Zurich, Switzerland
- Basel, Switzerland
- Santa Barbara, CA, United States

## People

- Bolyn Hubby — Chief of Staff
- Aimee Johnson — Chief Marketing Officer

## Questions

### How does the Parker Institute for Cancer Immunotherapy differ from a traditional cancer research grantmaker?

PICI is an active research institute, not a passive grantmaker. It directly coordinates collaborative projects among its network of partner cancer centers, sharing data and infrastructure to run joint clinical trials. The model is designed to remove institutional barriers and speed up the translation of scientific discoveries into patient treatments.

### Does the Parker Institute treat cancer patients directly?

No. PICI does not provide direct patient care. It collaborates with top-tier cancer research centers that do treat patients, facilitating clinical trials and research studies across its institutional network.

### Which research centers are part of the PICI network?

The network includes several of the most prominent cancer research institutions in the United States. Confirmed members include Stanford Medicine and Memorial Sloan Kettering Cancer Center, alongside other unlisted centers that collectively form the collaborative backbone of the institute.

### What is PICI’s geographic footprint?

The institute’s central operations are based in San Francisco, but it maintains a significant multi-hub presence. It lists additional locations in Boston, Santa Barbara, Zurich, and Basel, enabling it to coordinate transatlantic research efforts with European partners.

## Related profiles

- [CR Fuels](https://altss.com/profile/cr-fuels)
- [HLM Capital](https://altss.com/profile/hlm-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/parker-institute-for-cancer-immunotherapy

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology